http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012500692-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5608 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08 |
| filingDate | 2009-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012500692-A |
| titleOfInvention | MRI band diagnostic method based on non-point analysis |
| abstract | Solutions in the field of MRI-CEST for body part analysis are proposed. It contains a CEST contrast agent that provides the body's bulk matrix for magnetization transfer. Corresponding diagnostic system 100 includes input means for providing an input map including a plurality of input elements at each of the corresponding locations of the body part. Each input element represents a spectrum of the magnetic response of the location. Its spectrum consists of the magnetic response at the contrast agent drug resonance frequency (the drug frequency is the drug offset frequency offset from the bulk resonance frequency of the bulk matrix) and the reference frequency offset from the bulk frequency by the drug offset frequency. And magnetic response. The further system includes calculating means 555,563 for calculating drug values and reference values for each of a set of selected locations. The drug value is calculated, for example, by spectral integration in a non-point drug frequency range that includes the drug frequency. Further, the reference value is calculated, for example, by spectrum integration in a non-point-like reference frequency range including the reference frequency. Comparison between the drug value at the selected location and the reference value provides a comparison means 565 for calculating a parameter value for each selected location. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10234527-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016214301-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019505248-A |
| priorityDate | 2008-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160339 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572421 |
Total number of triples: 20.